These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35783293)

  • 21. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
    Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
    BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study.
    Campbell-Salome G; Morgan KM; Gabriel J; McGowan MP; Walters NL; Brangan A; Tricou EP; Rahm AK; Sturm AC; Jones LK
    J Clin Lipidol; 2024; 18(5):e832-e843. PubMed ID: 39278768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?
    Trevisan L; Godino L; Battistuzzi L; Innella G; Luppi E; Buzzatti G; Gismondi V; Blondeaux E; Bonelli LA; Turchetti D; Varesco L
    Fam Cancer; 2024 Jun; 23(2):197-207. PubMed ID: 37968543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic variants of familial hematuria associated genes in three families with hematuria with probands initially diagnosed as IgA nephropathy].
    Liu JW; Wang P; Huang J; Nie XJ; Zhao F; Chen LZ; Li Z; Yu ZH
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):674-679. PubMed ID: 31530352
    [No Abstract]   [Full Text] [Related]  

  • 26. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.
    Campbell-Salome G; Walters NL; Ladd IG; Sheldon A; Ahmed CD; Brangan A; McMinn MN; Rahm AK; Schwartz MLB; Tricou E; Fisher CL; Sturm AC
    Transl Behav Med; 2022 Jul; 12(7):800-809. PubMed ID: 35429393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.
    Blasi PR; Scrol A; Anderson ML; Gray MF; Tiffany B; Fullerton SM; Ralston JD; Leppig KA; Henrikson NB
    Pilot Feasibility Stud; 2022 Aug; 8(1):174. PubMed ID: 35945632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
    JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial disparities in cascade testing for cancer predisposition genes.
    Kassem NM; Althouse SK; Monahan PO; Hayes L; Nielsen SM; Heald B; Esplin ED; Hatchell KE; Ballinger TJ
    Prev Med; 2023 Jul; 172():107539. PubMed ID: 37156429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations.
    Alegre N; Perre PV; Bignon YJ; Michel A; Galibert V; Mophawe O; Corsini C; Coupier I; Chiesa J; Robert L; Bernhard L; Picot MC; Bertet H; Macioce V; Bastide N; Solassol J; Rey JM; Thomas F; Carton S; Pujol P
    Psychooncology; 2019 Aug; 28(8):1679-1686. PubMed ID: 31152683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.
    Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J
    Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing.
    Seven M; Shah LL; Yazici H; Daack-Hirsch S
    Cancer Nurs; 2022 Jan-Feb 01; 45(1):E91-E98. PubMed ID: 32804756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cascade testing for elevated lipoprotein(a) in relatives of probands with high lipoprotein(a).
    Chakraborty A; Chan DC; Ellis KL; Pang J; Barnett W; Woodward AM; Vorster M; Norman R; Moses EK; Watts GF
    Am J Prev Cardiol; 2022 Jun; 10():100343. PubMed ID: 35517871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.
    Quick CR; Conway KP; Swendsen J; Stapp EK; Cui L; Merikangas KR
    JAMA Psychiatry; 2022 Jul; 79(7):727-735. PubMed ID: 35648395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry.
    Gidding SS; Sheldon A; Neben CL; Williams HE; Law S; Zhou AY; Wilemon K; Ahmed CD; Kindt I
    J Clin Lipidol; 2020; 14(2):218-223.e2. PubMed ID: 32143996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    Modell SM; Greendale K; Citrin T; Kardia SL
    Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
    Ahsan MD; Levi SR; Webster EM; Bergeron H; Lin J; Narayan P; Nelson BB; Li X; Fowlkes RK; Brewer JT; Thomas C; Christos PJ; Chapman-Davis E; Cantillo E; Holcomb K; Sharaf RN; Frey MK
    PEC Innov; 2023 Dec; 2():100138. PubMed ID: 37214514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review.
    Sharaf RN; Myer P; Stave CD; Diamond LC; Ladabaum U
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1093-100. PubMed ID: 23669308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis.
    Cirino AL; Harris SL; Murad AM; Hansen B; Malinowski J; Natoli JL; Kelly MA; Christian S
    J Genet Couns; 2022 Dec; 31(6):1290-1305. PubMed ID: 35799446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.